Cargando…
Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
EGFR and KRAS mutations are two of the most common mutations that are present in lung cancer. Screening and detecting these mutations are of issue these days, and many different methods and tissue samples are currently used to effectively detect these two mutations. In this study, we aimed to evalua...
Autores principales: | Lee, Seung Eun, Lee, So-Young, Park, Hyung-Kyu, Oh, Seo-Young, Kim, Hee-Joung, Lee, Kye-Young, Kim, Wan-Seop |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951551/ https://www.ncbi.nlm.nih.gov/pubmed/27478332 http://dx.doi.org/10.3346/jkms.2016.31.8.1224 |
Ejemplares similares
-
Cumulative smoking dose affects the clinical outcomes of EGFR-mutated lung adenocarcinoma patients treated with EGFR-TKIs: a retrospective study
por: Kim, In Ae, et al.
Publicado: (2018) -
Extracellular Vesicle-Based Bronchoalveolar Lavage Fluid Liquid Biopsy for EGFR Mutation Testing in Advanced Non-Squamous NSCLC
por: Kim, In Ae, et al.
Publicado: (2022) -
A prospective phase 2 study of expeditious EGFR genotyping and immediate therapeutic initiation through extracellular vesicles (EV)-based bronchoalveolar lavage fluid (BALF) liquid biopsy in advanced NSCLC patients
por: Kim, In Ae, et al.
Publicado: (2023) -
Targeted Next-Generation Sequencing Analysis Predicts the Recurrence in Resected Lung Adenocarcinoma Harboring EGFR Mutations
por: Kim, In Ae, et al.
Publicado: (2021) -
Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
por: Kim, In Ae, et al.
Publicado: (2020)